Apollomics Inc. APLM

Healthcare — Biotechnology

22.35 (1.13) (4.81%) as of 25 Sep

Market cap: $68.4M
P/E: 0.0×

Follow APLM

Insider Buys (last 12m)

Insider Buys alert about insiders buying in the last 12 month

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Jun '24	Dec '24	Jun '25	Dec '25
ROE Full definition →	+8 more TTM periods Free account	0.00%	0.00%	0.00%	0.00%
ROA Full definition →		0.00%	0.00%	0.00%	0.00%
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		0.00%	0.00%	0.00%	0.00%
Average Days of Receivables Full definition →		—	—	0.00	0.00
Free Cash Flow per Share Full definition →		0.00	0.00	0.00	0.00
Free Cash Flow Full definition →		(126.76)	(112.33)	(95.50)	(62.67)
Capital Expenditures Full definition →		(0.34)	0.01	0.06	0.06
Other line items
Cash ROIC Full definition →		(251.61%)	(767.85%)	4,147.74%	(71,277.27%)
Share Based Compensation of Revenue Full definition →		—	—	0.00%	—
Operating CF/Net income Full definition →		0.00	0.00	0.00	0.00
Depreciation/Fixed assets Full definition →		16.13	3.08	137.20	5.44
Capex/Depreciation Full definition →		(0.17)	0.00	0.04	0.06
Operating CF per Share Full definition →		0.00	0.00	0.00	0.00
Capex per Share Full definition →		0.00	0.00	0.00	0.00
Capex to Sales Full definition →		0.00	0.00	0.00	0.00

Fold the line items

Columns are period end dates